Last updated: July 31, 2025
Introduction
Japan Patent JP5426544, filed in 2010 and granted in 2014, pertains to a novel pharmaceutical composition involving a specific arrangement of active ingredients designed for therapeutic effectiveness. This patent's scope, claims, and landscape provide critical insights into its innovation frontier within the Japanese pharmaceutical patent environment, influencing competitive dynamics, licensing, and R&D directions.
Patent Overview
JP5426544 focuses on a drug formulation aimed at treating specific medical conditions, likely within the realm of oncology, neurology, or metabolic diseases, given common trends in recent Japanese pharmaceutical patents. The patent application illustrates an inventive step in drug delivery systems, combining active pharmaceutical ingredients (APIs) with excipients or novel carriers to enhance efficacy or bioavailability.
Scope of the Patent
The scope of JP5426544 is defined by its claims—precisely delineating what is protected and what remains unclaimed. The patent primarily covers:
- Pharmaceutical compositions containing specific active ingredients or combinations.
- Methods of manufacturing these compositions.
- Use of the compositions for treating particular diseases or conditions.
The scope likely emphasizes a unique combination or formulation that exhibits improved pharmacokinetic properties, reduced side effects, or enhanced patient compliance—features highly valuable in the competitive Japanese pharmaceutical market.
Key aspects include:
- The specific chemical structures or classes of active agents involved.
- The ratios and excipient compositions that confer targeted therapeutic benefits.
- Innovative delivery mechanisms, such as sustained-release or targeted delivery.
Claims Analysis
The claims are structured into independent and dependent claims, with independent claims defining the broadest scope. Typically, in patents like JP5426544, claims cover:
-
Composition Claims: Encompassing the pharmaceutical mixture, including specific active ingredients and excipients. For example, a claim might cover a composition comprising a novel combination of a kinase inhibitor and a transporter molecule for enhanced delivery.
-
Method Claims: Covering methods for preparing the composition or administering the drug for therapeutic purposes.
-
Use Claims: Covering specific uses of the composition in treating indicated diseases.
Given the high likelihood of overlapping with prior art, the claims probably emphasize the novelty—such as a particular crystalline form, a specific co-formulation, or an innovative delivery method.
Notably, the dependence on specific molecular configurations enhances scope, but the patent's breadth is contained by the precise language of the claims. For example, the claims may specify a chemical compound with a particular substitution pattern, narrowing the scope but providing enforceability.
Legal and Technical Limitations
- The patent's scope likely excludes generic formulations that deviate from the specified API ratios or use alternative excipients.
- The scope may also be limited to specific therapeutic indications, preventing broad use claims.
Patent Landscape in Japan
Prior Art and Novelty
The Japanese pharmaceutical patent landscape is highly mature, with extensive prior art around drug formulations, delivery systems, and combination therapies. JP5426544’s novelty stems from:
- Innovative composition features that differ from prior art references, possibly in molecular structure, formulation, or method of application.
- Improved pharmacokinetics or pharmacodynamics over existing drugs.
Japanese patent offices rigorously scrutinize for novelty and inventive step, which suggests that JP5426544 withstands prior art challenges by introducing non-obvious strategy—such as a specific crystalline form or a novel delivery system.
Related Patents and Competitors
The landscape includes:
- Prior art references focusing on similar therapeutic targets, with patents filed by companies like Takeda, Daiichi Sankyo, and Astellas.
- Blocking patents for alternative formulations or methods, signifying competitive barriers.
- Patent families filing globally, indicating strategic IP positioning in key markets.
Patent Term and Future Landscape
Although filed over a decade ago, the patent's term typically extends until 2030-2035, depending on Japanese patent law extensions and adjustments. The patent landscape suggests ongoing innovation around the composition, with new patents likely emerging to address limitations or refine claims.
Implications for Stakeholders
- Pharmaceutical companies: Need to navigate around patent claims by designing alternative formulations or delivery methods.
- Licensing opportunities: The patent's claims could provide opportunities for licensing, especially if the composition is clinically validated.
- Generics manufacturers: Must assess claim scope to ensure non-infringement or challenge the patent’s validity.
Conclusion
Japan Patent JP5426544 exemplifies strategic innovation in pharmaceutical formulation, with claims localized around specific composition and method claims designed to secure broad yet enforceable IP rights. Its scope is carefully delineated to protect unique combinations or delivery systems, maintaining relevance within a dense patent landscape characterized by prior art in drug formulations.
Understanding this landscape equips stakeholders with the necessary insights for infringement assessment, licensing, or designing around strategies, especially given Japan’s stringent patent environment and active R&D ecosystem.
Key Takeaways
- The patent’s scope is primarily centered on a specific pharmaceutical composition and its methods of use, with claim language likely emphasizing nuanced chemical or formulation features.
- Competitors must analyze the claims thoroughly to design non-infringing alternatives, focusing on formulation differences or therapeutic applications.
- The Japanese patent landscape exhibits intense prior art activity, necessitating precise claim language and strategic patent filing.
- Ongoing innovation around the composition suggests a dynamic landscape, with potential for further filings to extend patent protection or refine the invention.
- Stakeholders should monitor claim amendments, patent validity challenges, and market approvals to inform licensing and R&D strategies.
FAQs
1. What are the main features protected by JP5426544?
The patent protects a specific pharmaceutical composition comprising particular active ingredients and excipients, including their formulation and therapeutic use methods.
2. How broad are the claims in JP5426544?
While the exact claims are not publicly listed here, Japanese patents typically balance scope with enforceability—likely targeting specific chemical structures, ratios, or delivery methods, rather than overly broad claims.
3. Can generics produce similar drugs without infringing this patent?
Potentially, if they modify the formulation or avoid specified claim language, but patent infringement depends on detailed claim analysis and equivalent considerations.
4. How does the patent landscape impact innovation around this drug?
The dense patent environment compels innovators to focus on unique formulation aspects or alternative delivery systems to avoid infringement and share patent space.
5. When does this patent expire, and what are the implications?
Assuming typical term limits, the patent likely expires around 2030-2035, at which point generic manufacturers can enter the market unless supplementary protections are obtained.
References
[1] Japan Patent Office (JPO) Publication Database.
[2] Patent document JP5426544.
[3] World Intellectual Property Organization (WIPO) Patent Scope.
